Myeloablative intravenous busulfan/fludarabine conditioning does not facilitate reliable engraftment of dual umbilical cord blood grafts in adult recipients (Q39258753)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Myeloablative intravenous busulfan/fludarabine conditioning does not facilitate reliable engraftment of dual umbilical cord blood grafts in adult recipients	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

10 September 2017

Myeloablative intravenous busulfan/fludarabine conditioning does not facilitate reliable engraftment of dual umbilical cord blood grafts in adult recipients (English)

1 reference

Europe PubMed Central

10 September 2017

Keith M. Sullivan

4

object named as

Keith Sullivan

1 reference

Europe PubMed Central

10 September 2017

Cristina Gasparetto

3

object named as

Cristina Gasparetto

1 reference

Europe PubMed Central

10 September 2017

7

object named as

David Rizzieri

1 reference

Europe PubMed Central

10 September 2017

9

object named as

Nelson Chao

1 reference

Europe PubMed Central

10 September 2017

5

object named as

Gwynn Long

1 reference

Europe PubMed Central

10 September 2017

Mitchell E Horwitz

1

object named as

Mitchell E Horwitz

1 reference

Europe PubMed Central

10 September 2017

6

object named as

John Chute

1 reference

Europe PubMed Central

10 September 2017

Ashley B. Morris

2

object named as

Ashley Morris

1 reference

Europe PubMed Central

10 September 2017

author name string

Jackie McPherson

8

1 reference

Europe PubMed Central

10 September 2017

publication date

1 May 2008

1 reference

Europe PubMed Central

10 September 2017

Biology of Blood and Marrow Transplantation

1 reference

Europe PubMed Central

10 September 2017

14

1 reference

Europe PubMed Central

10 September 2017

591-594

1 reference

Europe PubMed Central

10 September 2017

5

1 reference

Europe PubMed Central

10 September 2017

Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430979

10 September 2017

Double unrelated reduced-intensity umbilical cord blood transplantation in adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430979

10 September 2017

Cellular and clinical pharmacology of fludarabine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430979

10 September 2017

Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430979

10 September 2017

Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430979

17 June 2018

Clinical and pharmacologic effects of high dose single agent busulfan with autologous bone marrow support in the treatment of solid tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430979

17 June 2018

Effect of altering administration order of busulphan and cyclophosphamide on the myeloablative and immunosuppressive properties of the conditioning regimen in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430979

21 August 2018

Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430979

21 August 2018

Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430979

21 August 2018

Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430979

21 August 2018

Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2430979

2 December 2018

Measurement of busulfan in plasma by high-performance liquid chromatography

1 reference

https://pubmed.ncbi.nlm.nih.gov/18410902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.BBMT.2008.02.016

1 reference

Europe PubMed Central

10 September 2017

1 reference

Europe PubMed Central

10 September 2017

1 reference

Europe PubMed Central

10 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39258753&oldid=1816105410"